partnershipSecarna Pharmaceuticals partners with SciNeuro PharmaceuticalsLatest NewsAntisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases. Read more 27 March 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Brain_NIH.jpeg 832 1157 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-03-27 16:17:392024-07-12 12:20:44Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals